3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 4
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Spondylitis, Ankylosing
2
Psoriasis
2
Colitis, Ulcerative
2
Plaque Psoriasis
1
Osteoarthritis
1
Hidradenitis Suppurativa
1
Crohn Disease
1
Acne Vulgaris
1
Abscess
1
Interventions
etrolizumab
5
Adalimumab
2
Ringer's Lactate
1
Mesalamine
1
Loperamide
1
Injections
1
Infliximab
1
Hydroxyethyl Starch Derivatives
1
Andrographis paniculata extract
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Colitis, Ulcerative
×
Adalimumab
×
Clear all
NCT02163759
2021-07-23
HIBISCUS I
Hoffmann-La Roche
Phase 3
Completed
358 enrolled
42 charts
NCT02171429
2021-07-23
HIBISCUS II
Hoffmann-La Roche
Phase 3
Completed
358 enrolled
38 charts